In Brief:
Forty patients with methicillin-resistant Staph aureus or vancomycin-resistant Enterococcus infections were treated with the antibiotic linezolid, debridement, and wound coverage. Clinical success rates were 100% for skin and soft-tissue infections, 90% for osteomyelitis, and 83.3% for infections of wound coverage.